Potential roles of protease inhibitors in anticancer therapy
Authors:
- A. TrezzaATA. Trezza
- V. CicaloniVCV. Cicaloni
- F. PettiniFPF. Pettini
- O. SpigaOSO. Spiga
- 1 January 2020
- book chapter
- Published by Elsevier
- p. 13-49
Abstract
No abstract availableKeywords
This publication has 144 references indexed in Scilit:
- Protease signalling: the cutting edgeThe EMBO Journal, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Emerging principles in protease-based drug discoveryNature Reviews Drug Discovery, 2010
- Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsCancer and Metastasis Reviews, 2010
- Cathepsin H Is an Additional Convertase of Pro-granzyme BJournal of Biological Chemistry, 2010
- Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniaeMicrobial Pathogenesis, 2010
- Cathepsin L Is Responsible for Processing and Activation of Proheparanase through Multiple Cleavages of a Linker SegmentJournal of Biological Chemistry, 2008
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006